FDA Takes Further Steps to Streamline Biosimilar Development and Make Medicines More Affordable
March 09, 2026
March 09, 2026
WASHINGTON, March 9 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following news release:
* * *
FDA Takes Further Steps to Streamline Biosimilar Development and Make Medicines More Affordable
*
The U.S. Food and Drug Administration today announced another major step in its initiative to streamline the development of biosimilar medicines, which are like "generic" versions of biologic drugs. . . .
* * *
FDA Takes Further Steps to Streamline Biosimilar Development and Make Medicines More Affordable
*
The U.S. Food and Drug Administration today announced another major step in its initiative to streamline the development of biosimilar medicines, which are like "generic" versions of biologic drugs. . . .
